The biochemical mode of inhibition of DNA polymerase β by α-rubromycin

被引:22
作者
Mizushina, Y
Ueno, T
Oda, M
Yamaguchi, T
Saneyoshi, M
Sakaguchi, K
机构
[1] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan
[2] Japan Energy Co, Pharmaceut & Biotechnol Lab, Toda, Saitama 3358502, Japan
[3] Teikyo Univ Sci & Technol, Dept Biol Sci, Yamanashi 4090193, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2000年 / 1523卷 / 2-3期
关键词
alpha-rubromycin; beta-rubromycin; DNA polymerase beta; enzyme inhibitor; trypsin digestion;
D O I
10.1016/S0304-4165(00)00119-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quinone antibiotics, alpha- and beta -rubromycin, were originally found as inhibitors of retroviral reverse transcriptase. We investigated the effects of these agents on DNA metabolic enzymes including DNA and RNA polymerases as retroviral reverse transcriptase is a kind of the polymerase. As expected, we found that alpha- and beta -rubromycin strongly inhibited not only the retroviral reverse transcriptase activity, but the activities of the mammalian DNA polymerases, telomerase and terminal deoxynucleotidyl transferase in vitro. These agents should therefore be classified as DNA polymerase inhibitors. The Ki values of alpha -rubromycin against nucleotide substrate were 0.66 and 0.17 muM for DNA polymerase alpha and beta (pol. alpha and beta), respectively, and those of beta -rubromycin was 2.40 and 10.5 muM, respectively, alpha -Rubromycin strongly inhibited the pol. beta activity, and showed the strongest pol. beta inhibitory effect reported to date. At least on pol. beta, alpha -rubromycin was suggested to bind to the active region competing with the nucleotide substrate, and subsequently inhibit the catalytic activity. alpha -Rubromycin directly competed with the nucleotide substrate, and indirectly but simultaneously and non-competitively disturbed the template-DNA interaction with pol. beta. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:172 / 181
页数:10
相关论文
共 43 条
  • [1] Nitroalkenes as precursors to the aromatic spiroketal skeleton of γ-rubromycin.: A Nef-type reaction mediated by Pearlman's catalyst
    Capecchi, T
    de Koning, CB
    Michael, JP
    [J]. TETRAHEDRON LETTERS, 1998, 39 (30) : 5429 - 5432
  • [2] CASASFINET JR, 1991, J BIOL CHEM, V266, P19618
  • [3] CHEN J, 1998, J CHEM SOC CHEM COMM, V2769, P2769
  • [4] EXPRESSION OF ACTIVE-RAT DNA POLYMERASE-BETA IN ESCHERICHIA-COLI
    DATE, T
    YAMAGUCHI, M
    HIROSE, F
    NISHIMOTO, Y
    TANIHARA, K
    MATSUKAGE, A
    [J]. BIOCHEMISTRY, 1988, 27 (08) : 2983 - 2990
  • [5] 2.3-ANGSTROM CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF DNA POLYMERASE-BETA
    DAVIES, JF
    ALMASSY, RJ
    HOSTOMSKA, Z
    FERRE, RA
    HOSTOMSKY, Z
    [J]. CELL, 1994, 76 (06) : 1123 - 1133
  • [6] Harbinatic acid, a novel and potent DNA polymerase β inhibitor from Hardwickia binata
    Deng, JZ
    Starck, SR
    Hecht, SM
    Ijames, CF
    Hemling, ME
    [J]. JOURNAL OF NATURAL PRODUCTS, 1999, 62 (07): : 1000 - 1002
  • [7] Chrysochlamic acid, a new diterpenoid-substituted quinol from Chrysochlamys ulei that inhibits DNA polymerase β
    Deng, JZ
    Sun, DA
    Starck, SR
    Hecht, SM
    Cerny, RL
    Engen, JR
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1999, (09): : 1147 - 1149
  • [8] DNA polymerase β inhibitors from Baeckea gunniana
    Deng, JZ
    Starck, SR
    Hecht, SM
    [J]. JOURNAL OF NATURAL PRODUCTS, 1999, 62 (12): : 1624 - 1626
  • [9] DETERA SD, 1982, J BIOL CHEM, V257, P9770
  • [10] GOLDMAN ME, 1990, MOL PHARMACOL, V38, P20